CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma.

Int J Gen Med · 2022 · PMC9208739 · PMID 35734199

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a negative trendno p-value reported

A negative trend was found between expression of CLEC1B in HCC and the progression of tumor distant metastasis ( Figure 3A–N ).

also in 4,201 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.